{"slideshow_credits": null, "snippet": "Pfizer\u2019s latest offer for its rival seems cheap to shareholders who view AstraZeneca\u2019s turnaround as well advanced, Neil Unmack writes in Reuters Breakingviews.", "abstract": "Pfizer\u2019s latest offer for its rival seems cheap to shareholders who view AstraZeneca\u2019s turnaround as well advanced, Neil Unmack writes in Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Neil", "role": "reported", "lastname": "UNMACK", "rank": 1, "organization": ""}], "original": "By NEIL UNMACK"}, "web_url": "http://dealbook.nytimes.com/2014/05/02/pfizer-has-yet-to-make-a-compelling-bid-to-astrazenecas-shareholders/", "lead_paragraph": null, "headline": {"main": "Pfizer Has Yet to Make a Compelling Bid to AstraZeneca's Shareholders", "kicker": "DealBook"}, "_id": "5363cf7e38f0d8390028c8e2", "word_count": "406", "multimedia": [{"height": 126, "url": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 444, "url": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "444"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/03/business/dbpix-ian-read/dbpix-ian-read-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-02T13:00:17Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "Great Britain", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}